Your browser doesn't support javascript.
loading
Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology.
Samimi, Hilda; Haghpanah, Vahid.
Afiliação
  • Samimi H; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Haghpanah V; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran; Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran; Endocrinology and Metabolism Research Center (EMRC), Dr. Shariati Hospital, Tehran, Iran. Electronic address: v.haghpanah@gmail.com.
Trends Endocrinol Metab ; 31(9): 627-630, 2020 09.
Article em En | MEDLINE | ID: mdl-32273149
ABSTRACT
Gut microbiome (GM) might be associated with radioiodine (RAI)-refractory papillary thyroid carcinoma (PTC) through different mechanisms related to sodium/iodide (Na+/I-) symporter (NIS) regulation. However, whether thyroid carcinoma (TC), especially RAI-refractory PTC, causes dysbiosis, or vice versa, is still unknown. Further studies are needed to investigate the mechanism between GM and RAI-refractory PTC.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Microbioma Gastrointestinal / Câncer Papilífero da Tireoide / Radioisótopos do Iodo Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Microbioma Gastrointestinal / Câncer Papilífero da Tireoide / Radioisótopos do Iodo Idioma: En Ano de publicação: 2020 Tipo de documento: Article